NCT06184152Recruiting
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
Contrast Ultrasound vs. Abbreviated MRI for Detection of HCC in Patients With Indeterminate Liver Nodules
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Brief summary (registry, in English)
The study will be conducted at the following locations: 1. UT Southwestern Medical Center 2. Parkland Health and Hospital System 3. University of Michigan Investigators will prospectively compare the performance of dynamic contrast enhanced abbreviated MRI (AMRI) and contrast-enhanced ultrasound for early-stage HCC detection in patients with indeterminate liver nodules.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- First submitted
- 4 Dec 2023
- Start date
- 28 Nov 2023
- Primary completion date
- 28 Nov 2028
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06184152
What you commit to
- Study type: Interventional
- Planned participants: 600
- From 28 Nov 2023 to the primary completion date, 28 Nov 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients post liver transplantation
- Patients with concurrent or prior HCC (LR-5 or biopsy proven)
Other illness
- other liver cancer including cholangiocarcinoma
- Patients with any active extra-hepatic malignancy
- Patients with significant comorbidity and limited life expectancy, e.g., stage D congestive heart failure, in whom surveillance is not warranted are also excluded given unlikely clinical benefit
Other
- Patients with contraindication to contrast-enhanced MRI or CEUS, including implanted medical devices that are considered MR unsafe and severe claustrophobia
Who the study is looking for
- Child A or B cirrhosis from any etiology with at least one ILN on 4-phase CT, contrast- enhanced MRI, or contrast enhanced US but without HCC at baseline.
- Adults 18 years old and above
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Coordinator of this site? Confirm its status | Ann Arbor | United States | Recruiting |
| University of Texas Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.